Print

Galea Life Sciences' Subsidiary Awarded Presentation Slot for Clinical Policy Abstract At 15th International Symposium on HIV and Emerging Infectious Diseases  
4/1/2008 11:41:55 AM

MIAMI, April 1, 2008 (PRIME NEWSWIRE) -- Galea Life Sciences, Inc. (Pink Sheets:GLSN) announced that its BioSource Therapeutics, Inc. (BST) subsidiary will present its clinical policy abstract emphasizing the value of nutrition and protein in combating muscle and skeletal wasting at the 15th International Symposium on HIV and Emerging Infectious Diseases (ISHEID), May 28-30, in Toulon, France. BST is the maker of Nutraplete(tm) Therapeutic Drink Mix, the first dietary supplement product designed specifically for people living with HIV/AIDS.
//-->